Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 87Breast Neoplasms 49Prostatic Neoplasms 42Squamous Cell Carcinoma of Head and Neck 34Lung Neoplasms 24Neoplasms 19Stomach Neoplasms 18Head and Neck Neoplasms 17Neoplasm Metastasis 16Parkinson Disease 4, Autosomal Dominant Lewy Body 14Urinary Bladder Neoplasms 13Carcinoma, Transitional Cell 11Triple Negative Breast Neoplasms 10Ovarian Neoplasms 8Endometrial Neoplasms 8Carcinoma, Squamous Cell 8Adenocarcinoma 8HER2-positive Breast Cancer 7Non-Muscle Invasive Bladder Neoplasms 6Melanoma 6Carcinoma 6Small Cell Lung Carcinoma 5Prostatic Neoplasms, Castration-Resistant 5Nasopharyngeal Carcinoma 5Esophageal Neoplasms 5Uterine Cervical Neoplasms 4Sarcoma 4Oropharyngeal Neoplasms 4Fallopian Tube Neoplasms 4Esophageal Squamous Cell Carcinoma 4

Interventions

Nivolumab 2Docetaxel 2sitravatinib 1pembrolizumab 1Saline Solution 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Metastatic Non-Squamous Non-Small Cell Lung Cancer × Docetaxel × 1 year × Clear all
NCT07246863 2026-04-21

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

CatalYm GmbH

Phase 2 Recruiting
131 enrolled
Other solid neoplasmThoracic

Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT03906071 2025-10-21

SAPPHIRE

Mirati Therapeutics Inc.

Phase 3 Completed
577 enrolled 22 charts
Thoracic

Metastatic Non-Squamous Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡